# Vitalant – FDA Inspection, Feb 23, 2026

Source: https://www.keypedia.com/records/fda_inspections/vitalant/1a9a8191-f0d4-490f-8d79-ec3f649af69f
Source feed: FDA_Inspections

> FDA inspection 1304170 of Vitalant, February 23, 2026. 1 citation under 21 CFR part 606. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1304170
- Company Name: Vitalant
- Inspection Date: 2026-02-23
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Denver District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1172505 - 2022-06-09
- FDA Inspection 1040747 - 2018-01-26
- FDA Inspection 981946 - 2016-06-02
- FDA Inspection 858390 - 2013-12-11
- FDA Inspection 759960 - 2011-10-25

## Related Officers

- [FDA Personnel](https://www.keypedia.com/people/deepa-e-vadakkan/89c0e1c7-4f9e-4668-81a8-e5a9ab6a0e34)

Company: https://www.keypedia.com/companies/vitalant/f40b7ebb-291c-4345-896f-f7903f385f80

Office: https://www.keypedia.com/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face